These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 3285996

  • 21. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML, Chou YW, Chau YP, Huang TS.
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [Abstract] [Full Text] [Related]

  • 22. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
    Merzak A, Dooghe Y, Pironin M, Perbal B, Vigier P.
    Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
    [Abstract] [Full Text] [Related]

  • 23. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA, Wilson DJ, Ikejiri B, Roth JA, Grimm EA.
    J Immunol; 1986 Oct 15; 137(8):2716-20. PubMed ID: 3489774
    [Abstract] [Full Text] [Related]

  • 24. Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.
    Weyman CM, Taparowsky EJ, Wolfson M, Ashendel CL.
    Cancer Res; 1988 Nov 15; 48(22):6535-41. PubMed ID: 3052806
    [Abstract] [Full Text] [Related]

  • 25. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy.
    Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE.
    Cancer Res; 1990 May 01; 50(9):2840-7. PubMed ID: 2183932
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS, Cohen JD, Ehrlich LS, Bouck NP.
    Exp Cell Res; 1993 Apr 01; 205(2):232-9. PubMed ID: 8482334
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Malignant transformation of human fibroblasts by a transfected N-ras oncogene.
    Wilson DM, Yang DJ, Dillberger JE, Dietrich SE, Maher VM, McCormick JJ.
    Cancer Res; 1990 Sep 01; 50(17):5587-93. PubMed ID: 2201439
    [Abstract] [Full Text] [Related]

  • 33. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
    Reynolds SH, Patterson RM, Mennear JH, Maronpot RR, Anderson MW.
    Cancer Res; 1990 Jan 15; 50(2):266-72. PubMed ID: 2403837
    [Abstract] [Full Text] [Related]

  • 34. Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression.
    Gattoni-Celli S, Strauss RM, Willett CG, Pozzatti R, Isselbacher KJ.
    Cancer Res; 1989 Jun 15; 49(12):3392-5. PubMed ID: 2655894
    [Abstract] [Full Text] [Related]

  • 35. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ, Heaney ML, Parsons JT.
    Cancer Res; 1987 Aug 01; 47(15):4125-9. PubMed ID: 3300959
    [Abstract] [Full Text] [Related]

  • 36. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression.
    Samid D, Miller AC, Rimoldi D, Gafner J, Clark EP.
    Radiat Res; 1991 May 01; 126(2):244-50. PubMed ID: 2023995
    [Abstract] [Full Text] [Related]

  • 37. Transformation of rodent immortalized and embryo cells by oncogenes. I. Mouse (NIH 3T3) and rat (FR 3T3) immortalized fibroblasts.
    Denner J, Ehm I, Jandrig B, Friese D.
    Arch Geschwulstforsch; 1987 May 01; 57(6):463-74. PubMed ID: 3435225
    [Abstract] [Full Text] [Related]

  • 38. Transfection of EK-3, a subline of NIH 3T3, with the oncogene Ha-ras does not abolish its anchorage dependence.
    Katz E, Samid D.
    Eur J Cell Biol; 1989 Aug 01; 49(2):221-4. PubMed ID: 2673787
    [Abstract] [Full Text] [Related]

  • 39. In vitro and in vivo onco-suppressor activity of normal cells on cells transformed with the H-ras1 oncogene.
    Kakkanas A, Spandidos DA.
    In Vivo; 1990 Aug 01; 4(2):109-14. PubMed ID: 2129801
    [Abstract] [Full Text] [Related]

  • 40. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW, Trimble WS, Hozumi N, Roder JC.
    J Immunol; 1987 Jun 01; 138(11):3996-4003. PubMed ID: 3495578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.